Literature DB >> 168832

Mutants of Serratia marcescens lacking cyclic nucleotide phosphodiesterase activity and requiring cyclic 3',5'-AMP for the utilization of various carbohydrates.

U Winkler, H Scholle, L Bohne.   

Abstract

Adenine requiring mutants of Serratia marcescens SM-6-F'lac+ have been found to grow well in minimal-glucose medium solely supplemented with cAMP. From one of these ade strains double mutants (called ade cpd) were isolated which could no longer utilize cAMP but which still grew on 5'AMP. Dialyzed cell extracts (soluble fraction) of the double mutants, assayed for cAMP phosphodiesterase, were unable to hydrolyze cAMP whereas cell extracts of the parental strains yielded 5'AMP at a rate of 1.6-2.0 mumoles min-1 mg-1 protein. The loss of the phosphodiesterase activity in S. marcescens cpd W 1181 did not cause an accumulation of large amounts of cAMP as was found for the diesterase-negative mutant AB257pc-1 of Escherichia coli. The induced synthesis of beta-galactosidase in mutant cpd W 1181 showed about the same sensitivity to transient and permanent catabolite (glucose) repression as the corresponding cpd+ strain. Starting from S. marcescens cpd W 1182 three independent double mutants (called cpd cya) were isolated which required exogenous cAMP for utilizing various carbohydrates as carbon source, for motility and for the formation of extracellular lipase and the red pigment prodigiosine. The intracellular concentration of cAMP in these mutants, grown in nutrient broth, was 40-60% of that of the parental strain which is about 4 x 10(-4) M. However, the adenylate cyclase in cell extracts of the mutants W 1237 and W 1270 was like that of the corresponding cya+ strain (about 2 x 10(-2) mumoles min-1 mg-1 protein).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168832     DOI: 10.1007/bf00447323

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  21 in total

1.  Cyclic 3', 5'-adenosine monophosphate phosphodiesterase mutants of Salmonella typhimurium.

Authors:  M D Alper; B N Ames
Journal:  J Bacteriol       Date:  1975-06       Impact factor: 3.490

2.  Pleiotropic mutations in Serratia marcescens which increase the synthesis of certain exocellular proteins and the rate of spontaneous prophage induction.

Authors:  U Winkler; K Timmis
Journal:  Mol Gen Genet       Date:  1973-08-17

3.  Cyclic 3',5'-nucleotide phosphodiesterase of Serratia marcescens.

Authors:  T Okabayashi; M Ide
Journal:  Biochim Biophys Acta       Date:  1970-10-14

4.  Cyclic AMP receptor protein of E. coli: its role in the synthesis of inducible enzymes.

Authors:  M Emmer; B deCrombrugghe; I Pastan; R Perlman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

5.  Cyclic 3',5'-nucleotide phosphodiesterase. Preparation of a partially inactive enzyme and its subsequent stimulation by snake venom.

Authors:  W Y Cheung
Journal:  Biochim Biophys Acta       Date:  1969-11-04

6.  Genetic evidence for the role of a bacterial phosphotransferase system in sugar transport.

Authors:  R D Simoni; M Levinthal; F D Kundig; W Kundig; B Anderson; P E Hartman; S Roseman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-11       Impact factor: 11.205

7.  Adenyl cyclase of Escherichia coli.

Authors:  M Ide
Journal:  Biochem Biophys Res Commun       Date:  1969-07-07       Impact factor: 3.575

8.  Cyclic adenosine 3',5'-monophosphate in Escherichia coli.

Authors:  M J Buettner; E Spitz; H V Rickenberg
Journal:  J Bacteriol       Date:  1973-06       Impact factor: 3.490

9.  Requirement of adenosine 3', 5'-cyclic phosphate for flagella formation in Escherichia coli and Salmonella typhimurium.

Authors:  T Yokota; J S Gots
Journal:  J Bacteriol       Date:  1970-08       Impact factor: 3.490

10.  Cyclic adenosine monophosphate in bacteria.

Authors:  I Pastan; R Perlman
Journal:  Science       Date:  1970-07-24       Impact factor: 47.728

View more
  10 in total

Review 1.  Extracellular enzyme synthesis in the genus Bacillus.

Authors:  F G Priest
Journal:  Bacteriol Rev       Date:  1977-09

Review 2.  Cyclic nucleotides in procaryotes.

Authors:  J L Botsford
Journal:  Microbiol Rev       Date:  1981-12

3.  Glycogen, hyaluronate, and some other polysaccharides greatly enhance the formation of exolipase by Serratia marcescens.

Authors:  U K Winkler; M Stuckmann
Journal:  J Bacteriol       Date:  1979-06       Impact factor: 3.490

4.  Methyl ester of hyaluronate is unable to stimulate exolipase formation by Serratia marcescens.

Authors:  K E Jäger; U K Winkler
Journal:  J Bacteriol       Date:  1979-09       Impact factor: 3.490

5.  Pleiotropic consequences of mutations towards antibiotic-hypersensitivity in Serratia marcescens.

Authors:  U Winkler; K B Heller; B Folle
Journal:  Arch Microbiol       Date:  1978-03       Impact factor: 2.552

6.  Cyclic AMP phosphodiesterase in Salmonella typhimurium: characteristics and physiological function.

Authors:  J L Botsford
Journal:  J Bacteriol       Date:  1984-11       Impact factor: 3.490

7.  The cyclic AMP-dependent catabolite repression system of Serratia marcescens mediates biofilm formation through regulation of type 1 fimbriae.

Authors:  Eric J Kalivoda; Nicholas A Stella; Dawn M O'Dee; Gerard J Nau; Robert M Q Shanks
Journal:  Appl Environ Microbiol       Date:  2008-04-18       Impact factor: 4.792

8.  Relaxed mutants of Serratia marcescens SM-6. Biochemical traits and relevance of the rel+ allele for the formation of exoenzymes.

Authors:  L Bohne; U Winkler
Journal:  Arch Microbiol       Date:  1979-05       Impact factor: 2.552

9.  Cyclic AMP negatively regulates prodigiosin production by Serratia marcescens.

Authors:  Eric J Kalivoda; Nicholas A Stella; Marissa A Aston; James E Fender; Paul P Thompson; Regis P Kowalski; Robert M Q Shanks
Journal:  Res Microbiol       Date:  2010-01-04       Impact factor: 3.992

10.  Bacterial cyclic AMP-phosphodiesterase activity coordinates biofilm formation.

Authors:  Eric J Kalivoda; Kimberly M Brothers; Nicholas A Stella; Matthew J Schmitt; Robert M Q Shanks
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.